Inventor
PERERA TIMOTHY PIETRO SUREN
BE22 patents
⚠️ This page may combine multiple inventors who share the name “PERERA TIMOTHY PIETRO SUREN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
11 patentsUS7799772B2Sep 21, 2010
Pyrido-and pyrimidopyrimidine derivatives as anti-profilerative agents
JANSSEN PHARMACEUTICA NV16 citations92
US7648975B2Jan 19, 2010
Macrocyclic quinazoline derivatives as antiproliferative agents
JANSSEN PHARMACEUTICA NV12 citations83
US7655642B2Feb 2, 2010
3-cyano-quinoline derivatives with antiproliferative activity
JANSSEN PHARMACEUTICA NV13 citations82
US10138246B2Nov 27, 2018
Deuterated triazolopyridazine as a kinase modulator
JANSSEN PHARMACEUTICA NV2 citations67
US7947695B2May 24, 2011
5-membered annelated heterocyclic pyrimidines as kinase inhibitors
JANSSEN PHARMACEUTICA NV4 citations60
US7947694B2May 24, 2011
Substituted pyrazolo[3,4-D]pyrimidines as cell cycle kinase inhibitors
JANSSEN PHARMACEUTICA NV2 citations60
US9365517B2Jun 14, 2016
3-cyano-quinoline derivatives with antiproliferative activity
JANSSEN PHARMACEUTICA NV0 citations51
US9273013B2Mar 1, 2016
Quinazoline derivatives
JANSSEN PHARMACEUTICA NV0 citations51
US9040511B2May 26, 2015
3-cyano-quinoline derivatives with antiproliferative activity
JANSSEN PHARMACEUTICA NV0 citations51
US10464939B2Nov 5, 2019
Deuterated triazolopyridazine as a kinase modulator
JANSSEN PHARMACEUTICA NV0 citations48
US8933067B2Jan 13, 2015
Pyrido and pyrimidopyrimidine derivatives as anti-profilerative agents
JANSSEN PHARMACEUTICA NV0 citations48
ASTEX THERAPEUTICS LTD
7 patentsUS9464071B2Oct 11, 2016
Pyrazolyl quinoxaline kinase inhibitors
ASTEX THERAPEUTICS LTD24 citations93
US9850228B2Dec 26, 2017
Pyrazolyl quinoxaline kinase inhibitors
ASTEX THERAPEUTICS LTD17 citations91
US10519137B2Dec 31, 2019
Pyrazolyl quinoxaline kinase inhibitors
ASTEX THERAPEUTICS LTD6 citations83
US10085982B2Oct 2, 2018
Combinations
ASTEX THERAPEUTICS LTD12 citations81
US10736900B2Aug 11, 2020
Combinations of an FGFR inhibitor and an IGF1R inhibitor
ASTEX THERAPEUTICS LTD4 citations70
US10716787B2Jul 21, 2020
Combinations
ASTEX THERAPEUTICS LTD3 citations70
US11918576B2Mar 5, 2024
Combination of an FGFR inhibitor and a CMET inhibitor
ASTEX THERAPEUTICS LTD0 citations59
FREYNE EDDY JEAN EDGARD
3 patentsUS8394786B2Mar 12, 2013
Quinazoline derivatives
FREYNE EDDY JEAN EDGARD5 citations82
US8772272B2Jul 8, 2014
Pyrido-and pyrimidopyrimidine derivatives as anti-proliferative agents
FREYNE EDDY JEAN EDGARD0 citations49
US8778920B2Jul 15, 2014
3-cyano-quinoline derivatives with antiproliferative activity
FREYNE EDDY JEAN EDGARD0 citations47